Free Trial

RWA Wealth Partners LLC Cuts Stock Position in Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Finance background

Key Points

  • RWA Wealth Partners LLC reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 44.7%, selling 17,093 shares and holding 21,121 shares valued at $427,000 as of the last reporting period.
  • Healthpeak Properties reported $0.46 earnings per share for the last quarter, matching analysts' expectations, with a slight decline in revenue year-over-year.
  • The company announced a dividend of $0.1017 per share, with a payout ratio of 508.33%, and the dividend will be paid on August 29th to shareholders recorded by August 19th.
  • Interested in Healthpeak Properties? Here are five stocks we like better.

RWA Wealth Partners LLC cut its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 44.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,121 shares of the real estate investment trust's stock after selling 17,093 shares during the quarter. RWA Wealth Partners LLC's holdings in Healthpeak Properties were worth $427,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Townsquare Capital LLC raised its holdings in Healthpeak Properties by 5.9% in the fourth quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock worth $212,000 after buying an additional 584 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of Healthpeak Properties by 10.5% during the fourth quarter. NewEdge Advisors LLC now owns 14,409 shares of the real estate investment trust's stock valued at $292,000 after acquiring an additional 1,371 shares in the last quarter. First Trust Advisors LP increased its position in shares of Healthpeak Properties by 231.8% during the fourth quarter. First Trust Advisors LP now owns 478,098 shares of the real estate investment trust's stock valued at $9,691,000 after acquiring an additional 333,998 shares in the last quarter. MetLife Investment Management LLC raised its holdings in Healthpeak Properties by 0.7% in the 4th quarter. MetLife Investment Management LLC now owns 205,644 shares of the real estate investment trust's stock worth $4,168,000 after acquiring an additional 1,380 shares during the last quarter. Finally, MML Investors Services LLC lifted its position in Healthpeak Properties by 2.0% in the 4th quarter. MML Investors Services LLC now owns 172,276 shares of the real estate investment trust's stock valued at $3,492,000 after acquiring an additional 3,351 shares in the last quarter. Institutional investors own 93.57% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DOC. Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Evercore ISI dropped their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Argus reiterated a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $21.70.

View Our Latest Stock Analysis on DOC

Insider Transactions at Healthpeak Properties

In related news, Director Tommy G. Thompson acquired 5,777 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was bought at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director owned 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Scott M. Brinker bought 2,930 shares of Healthpeak Properties stock in a transaction that occurred on Thursday, July 31st. The stock was purchased at an average cost of $17.06 per share, with a total value of $49,985.80. Following the completion of the acquisition, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This represents a 1.41% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 14,560 shares of company stock worth $249,898. Insiders own 0.23% of the company's stock.

Healthpeak Properties Stock Performance

Shares of DOC stock traded down $0.12 during mid-day trading on Tuesday, reaching $17.54. 9,519,723 shares of the company's stock traded hands, compared to its average volume of 7,810,007. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $23.26. The firm has a 50 day moving average price of $17.64 and a two-hundred day moving average price of $18.34. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The firm has a market capitalization of $12.19 billion, a PE ratio of 73.07, a price-to-earnings-growth ratio of 2.26 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.Healthpeak Properties's revenue for the quarter was down .2% compared to the same quarter last year. During the same period last year, the firm earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

See Also

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.